INTAI Technology Corporation, founded in 1988 and headquartered in Taichung, Taiwan, manufactures precision components and assemblies for the medical device, automotive, aerospace, precision hardware, and electronic communication industries in Taiwan and internationally; its core offerings include standard and customized precision hardware products such as metal machining, forming, material removal, and gear manufacturing; medical components for endoscopic minimally invasive surgery, breast biopsy devices, disposable and reusable applications, orthopedic implants including thoracolumbar and cervical sets, pedicle screws, PEEK and titanium cages, trauma screws and plates, and surgical instruments; RF and microwave products for commercial, wireless, automotive, and telecommunication sectors; as well as advanced processes encompassing molding via injection and metal injection molding (MIM), secondary operations like shaping, lapping, grinding, surface treatment, coating, and heat treatment, laser manufacturing for cutting, welding, and marking, unique material applications including Nitinol and coiling, and full assembly services in ISO 13485-certified and FDA-registered facilities. The company operates facilities including its JingKe headquarters established in 2012 in Taichung Precision Machinery Innovation Technology Park and the HouLi facility opened in 2023 to support expanded capacity. In 2025, INTAI participated as a new investor in Imperative Care's oversubscribed Series E financing round potentially reaching $150 million, led by Ally Bridge Group, underscoring its strategic push into medical technology investments alongside ongoing enhancements in vacuum heat-treatment furnaces and lean manufacturing implemented since 2015.